This is early beta for now! Can't handle all templates properly

Hankkija

Vastaanotettu Hilmaan2022-11-01
Ilmoituksen numero2022-111945
TED numero2022/S 213-609864
OstajaorganisaatioHelsingin ja Uudenmaan Sairaanhoitopiirin kuntayhtymä (1567535-0 )
Uutistie 3
FI-01770 Vantaa
http://www.hus.fi
Hankinnan otsikkotiedotREQUEST FOR INFORMATION: Fusion gene test (Ts-TmrFuus 21736, Ts-SarFuus 23109, Ts-HemFuus 23108)
Hankinnan yhteenlaskettu kokonaisarvo koko ajalle (ilman alv:ta) arvio
Hankinnan yhteenlaskettu kokonaisarvo koko ajalle (ilman alv:ta) lopullinen
Alkuperäinen ilmoitushttps://www.hankintailmoitukset.fi/en/public/procurement/77537/notice/111945/overview
Originaali JSON tietue111945.json

Ostettava

Hankinnan lyhyt kuvausThis is not a call for tenders and we are not asking for any offers via this announcement. This prior information notice does not obligate the procurement unit for any actions. All information presented in this prior information notice is preliminary and indicative. This notice is not binding on any kind of solutions or actions. The suppliers are not paid for responding to this request for information or participating in a possible technical dialogue. HUSLAB Laboratory of Genetics at HUS (Helsinki University Hospital) Diagnostic Center is a SFS-EN ISO 15189:2013 accredited laboratory providing diagnostic genetic testing services to all patients at Helsinki University Hospital area. The services include analysis of both constitutional samples and malignancies. The laboratory provides sequencing services mainly using local HUSLAB sequencing capacity (Illumina NovaSeq 6000 and Ion Torrent S5 equipment). Currently HUSLAB is performing gene fusion panels for sarcomas, hematological disorders, solid tumors such as lung, cholangiocarcinoma, thyroid, brain. Gene fusions are based on analysis of total nucleic acids extracted on paraffin embedded blocks or RNA on fresh samples using next generation sequencing (NGS) on Ion Torrent sequencers. The annual number of fusion gene tests performed is 700. No major changes in test volume are expected. We kindly ask your answers to the following specific requirements and questions concerning the gene fusion tests: - Which test is used for gene fusion and is the test CE-IVD marked (IVDR)? - The test is validated for Ion Torrent S5 equipment. (Yes/No) - The test is validated for Illumina NovaSeq 6000. (Yes/No) - The test is validated for paraffin embedded samples and fresh samples. (Yes/No) - The automatic extraction methods (Maxwell, QIAsymphony) are suitable for tests. (Yes/No) - The gene panel covers the most common fusions (at least EWSR1, SS18, FUS, PAX3, PDGFB, USP6, CIC, NTRKs, TFE3, BCOR) in sarcomas. (Yes/No) - The gene panel covers the most common fusions (at least KMT2A, ABL1, CRLF2, BCL2, ETV6, MLLT10, RUNX1, TCF3) in hematological samples. (Yes/No) - The gene panel covers the most common exon skipping (at least IKZF1) in hematological samples. (Yes/No) - The gene panel covers expression levels (at least ABL1, CRLF2) in hematological samples. (Yes/No) - The gene panel covers the most common fusions (ALK, ROS1, RET, BRAF, NTRKs) in solid tumors. (Yes/No) - The gene panel covers the most common exon skipping (at least MET exon 14) in solid tumors (Yes/No) - Novel fusion partners are identified. (Yes/No) - Allele frequency, breakpoints and sequence are reported. (Yes/No) - SNVs and indels can be detected in same run as fusion genes ? - What is the limit od detection (LOD) ? - How many samples can be run in one chip/flow cell ? The response to this gene fusion test information request should include descriptions to the above questions. The answers to this request for information are asked to be sent by e-mail to [email protected]. We ask you to send responses to this request latest on November 10th 2022.
Hankintanimikkeistö (CPV) pääLaboratory reagents (33696500)
Hankintanimikkeistö (CPV) muut
AluekoodiFI1
Pääasiallinen suorituspaikka

Sopimukset